Allers, CarolinaCarolinaAllersSierralta, Walter D.Walter D.SierraltaNeubauer, SoniaSoniaNeubauerRivera, FranciscoFranciscoRiveraMinguell, José J.José J.MinguellCONGET MOLINA, PAULETTE ANDREAPAULETTE ANDREACONGET MOLINA2023-07-042023-07-042004-08-27https://investigadores.udd.cl/handle/123456789/718610.1097/01.TP.0000128334.93343.B32-s2.0-414312229215446307Background. The use of mesenchymal stem cells (MSC) for cell therapy relies on their capacity to engraft and survive long term in the appropriate target tissue(s). Animal models have demonstrated that the syngeneic or xenogeneic transplantation of MSC results in donor engraftment into the bone marrow and other tissues of conditioned recipients. However, there are no reliable data showing the fate of human MSC infused into conditioned or unconditioned adult recipients. Methods. In the present study, the authors investigated, by using imaging, polymerase chain reaction (PCR), and in situ hybridization, the biodistribution of human bone marrow-derived MSC after intravenous infusion into unconditioned adult nude mice. Results. As assessed by imaging (gamma camera), PCR, and in situ hybridization analysis, the authors' results demonstrate the presence of human MSC in bone marrow, spleen, and mesenchymal tissues of recipient mice. Conclusions. These results suggest that human MSC transplantation into unconditioned recipients represents an option for providing cellular therapy and avoids the complications associated with drugs or radiation conditioning.Resource Types::text::journal::journal article